Skip to main content
OpenTrials
Completed

NCT Number: NCT01691144

Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project

Follow-up of cancer patients accounts for a substantial part of outpatient activity, and alternative models of care are developing. In some countries, low-risk follow-up is already done in primary care, mainly in breast, and colorectal cancer. In this study the investigators will explore gynecological cancer patients about their expectations regarding their future follow-up plan. Further, the investigators will ask about the experience and satisfaction among patients who have already attended a follow-up programme for 2-3 years. In addition, the investigators will especially focus on the cooperation aspect between primary and secondary care. The investigators hypothesize that follow-up of selected gynecological cancer patients can be done by general practitioners.

Completed

Looking for future studies?

Notify Me

Key information

About this study

After gynaecological cancer patients have completed their treatment, they are followed up at a gynaecological outpatient clinic for a number of years. The aim of such follow-up is to detect recurrence, improve survival and reduce adverse effects of the treatment. The national guide for oncological gynaecology recommends follow-up by a specialist for five years at intervals depending on cancer type. Several review studies on follow-up of endometrial, cervical and ovarian cancer patients show large international variations in follow-up routines. There are only retrospective studies available, and they indicate that most recurrences are discovered within the first three years after completed treatment, and, in most cases, by the women themselves. More intensive surveillance does not appear to affect the time for discovery of recurrence.

A few randomised controlled studies and retrospective cohort studies have been published that focus on follow-up of colon cancer and breast cancer patients by general practitioners versus by hospital specialists. These studies have not shown any significant differences between the groups in terms of detection of recurrence, incidence of serious clinical events connected with recurrence or health-related quality of life.

The investigators therefore plan to perform a study in which both gynaecological cancer patients and their regular general practitioners are asked about their views on patient follow-up after completed treatment. The investigators especially wish to focus on the collaboration aspect.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • > 18 years
  • histologically or cytologically proven cancer

Exclusion criteria

  • Unability to fill out questionnaires (due to language or cognitive barriers)

Treatment and study plan

Primary outcomes

  1. Patient expectation questionnaire

    Time frame: within the first 30 days after primary treatment

    The patients will be asked to fill in a quesionnaire regarding their expectations on follow-up care

Secondary outcomes

  1. Patient satisfaction questionnaire

    Time frame: 3 years after treatment

    The patients will be asked to fill in a quesionnaire regarding their satisfaction on follow-up care after three years

Sponsors and collaborators

Lead sponsor

University of Oslo

Other

Registry information

Official study title

Gynecological Cancer Survivors' Views on Follow-up After Cancer Treatment

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Sep 24, 2012
Registry last updated
May 12, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.